4.66
price up icon1.53%   0.07
after-market After Hours: 4.66
loading
Evoke Pharma Inc stock is traded at $4.66, with a volume of 15,120. It is up +1.53% in the last 24 hours and down -9.86% over the past month. Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$4.59
Open:
$4.55
24h Volume:
15,120
Relative Volume:
0.08
Market Cap:
$7.26M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.4225
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-0.43%
1M Performance:
-9.86%
6M Performance:
+111.82%
1Y Performance:
-10.21%
1-Day Range:
Value
$4.41
$4.66
1-Week Range:
Value
$4.3904
$4.88
52-Week Range:
Value
$1.94
$12.32

Evoke Pharma Inc Stock (EVOK) Company Profile

Name
Name
Evoke Pharma Inc
Name
Phone
858-345-1494
Name
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
EVOK's Discussions on Twitter

Compare EVOK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EVOK
Evoke Pharma Inc
4.66 7.15M 8.62M -6.15M -5.32M -11.03
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.26 62.54B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 43.30B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.08 40.08B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.02 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.06 19.90B 3.08B 1.24B 1.07B 25.61

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-22-20 Upgrade H.C. Wainwright Neutral → Buy
Mar-05-19 Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18 Reiterated B. Riley FBR, Inc. Buy
Oct-19-17 Resumed FBR & Co. Buy
Mar-16-17 Reiterated Rodman & Renshaw Buy
Jan-30-17 Upgrade Laidlaw Neutral → Buy
Jan-05-17 Upgrade Rodman & Renshaw Neutral → Buy
Dec-23-16 Reiterated Rodman & Renshaw Neutral
Jul-19-16 Reiterated FBR Capital Outperform
Jul-19-16 Downgrade Noble Financial Buy → Hold
Jul-18-16 Downgrade Rodman & Renshaw Buy → Neutral
Mar-16-16 Initiated Northland Capital Outperform
Mar-14-16 Reiterated Ascendiant Capital Markets Buy
Feb-17-16 Resumed FBR Capital Outperform
Dec-03-14 Reiterated MLV & Co Buy
Nov-07-14 Initiated MLV & Co Buy
Apr-22-14 Initiated Laidlaw Buy
Nov-19-13 Initiated Aegis Capital Buy
View All

Evoke Pharma Inc Stock (EVOK) Latest News

pulisher
10:50 AM

How currency fluctuations impact Evoke Pharma Inc. stockJuly 2025 Update & Technical Buy Zone Confirmation - newser.com

10:50 AM
pulisher
09:58 AM

Evoke Pharma Inc.’s volatility index tracking explainedSwing Trade & Expert Curated Trade Setups - newser.com

09:58 AM
pulisher
01:18 AM

What valuation multiples suggest for Evoke Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - newser.com

01:18 AM
pulisher
Oct 12, 2025

Does Evoke Pharma Inc. fit your quant trading modelGlobal Markets & Technical Buy Zone Confirmations - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Real time alert setup for Evoke Pharma Inc. performanceDay Trade & Free Community Consensus Stock Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Using data tools to time your Evoke Pharma Inc. exitMarket Trend Report & Consistent Income Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Short interest data insights for Evoke Pharma Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What to expect from Evoke Pharma Inc. in the next 30 daysDay Trade & Daily Profit Maximizing Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates “Sell (E+)” Rating for Evoke Pharma (NASDAQ:EVOK) - Defense World

Oct 09, 2025
pulisher
Oct 06, 2025

Will Evoke Pharma Inc. stock recover after recent drop2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Sector ETF performance correlation with Evoke Pharma Inc.Trade Entry Report & Verified Entry Point Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Institutional scanner results for Evoke Pharma Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Will Evoke Pharma Inc. stock return to pre crisis levelsJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

How to monitor Evoke Pharma Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

What Fibonacci levels say about Evoke Pharma Inc. rebound2025 Market Overview & Growth Focused Investment Plans - newser.com

Sep 30, 2025
pulisher
Sep 28, 2025

Is Evoke Pharma Inc a good long term investmentLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

News impact scoring models applied to Evoke Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Will Evoke Pharma Inc. continue its uptrend2025 Price Targets & AI Driven Stock Movement Reports - newser.com

Sep 27, 2025

Evoke Pharma Inc Stock (EVOK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.04
price up icon 1.42%
$9.86
price up icon 1.23%
$54.73
price up icon 1.45%
drug_manufacturers_specialty_generic RDY
$14.36
price up icon 0.14%
$137.35
price up icon 0.53%
$440.06
price up icon 0.01%
Cap:     |  Volume (24h):